Examination of Survivorship Care Planning Efficacy and Impact (R01) and (R21)

PA-16-012
Examination of Survivorship Care Planning Efficacy and Impact (R01)
Department of Health and Human Services
National Institutes of Healthplan_beyond_cancer-slider

Specific Research Objectives

Applications are expected to assess whether care planning renders added benefits in terms of reducing morbidity, increasing adherence to follow-up guidelines, better self-management of late effects, appropriate utilization of follow-up care, and reduced cost.  The proposed research should also evaluate the pathways and processes through which such benefit is derived and clarify to whom such benefits accrue (survivors, clinicians, delivery systems, payers). Transdisciplinary approaches that link health services and health economics research with clinical, behavioral, and social science disciplines are encouraged. Studies documenting the organizational context and key processes through which successful care planning occurs are invited, including those that study how the generation and use of survivorship care plans intersects with processes of care delivery, inter-provider communication, patient-provider communication, and meaningful use of informatics. Studies linking care planning to use of electronic medical records, and exploring ways to harness electronic platforms, tools and applications are encouraged. Studies of how successful care planning initiatives are implemented in a variety of healthcare and community practice settings are encouraged. Studies may include family and caregiver outcomes in addition to survivor outcomes. Studies that will be considered for funding are limited to those that focus on individuals diagnosed with cancer at age 21 or older.

Research Applications are particularly encouraged to consider the following issues in the Research Strategy:

  • Inclusion of at least one survivor-level outcome (behavioral, physical and/or psychosocial morbidity) and at least one provider or system-level outcome (service use, time use, knowledge) related to care delivery or cost.
  • Studies assessing the impact of care planning or identifying effective models of care are expected to use comparative designs (randomized controlled trials, quasi-experimental, case-control, interrupted time series, or similar designs) that allow comparison of care planning strategies.
  • Adjunctive qualitative or quantitative observational approaches are encouraged in the context of the above designs.
  • Because the standard of care is not yet consistently established, investigators are expected to carefully document and describe the care planning protocol studied in all inquiries. Studies are encouraged to use care plans that include, but are not limited to, Institute of Medicine-recommended content for survivorship care plans.
  • Studies focused on the development and testing of instruments to evaluate survivorship care planning may use the R01 mechanism or the companion R21 mechanism, as appropriate.

Research areas of interest include, but are not limited, to:

  • What are the best constructs and outcomes for evaluating survivorship care planning and which metrics are best suited to measure these?
  • What is the impact of survivorship care planning on cancer survivors’ post-treatment psychosocial and physiologic morbidity?
  • What is the effect of survivorship care planning on adherence to screening recommendations, preventive behaviors, and self-management of late and long-term effects of cancer?
  • What is the optimal timing for delivery of survivorship care planning?
  • Does survivorship care planning decrease unnecessary health care resource utilization?
  • What are the differential costs associated with the generation and implementation of care plans versus usual care, and what value is added, if any?
  • How do care plans affect the number of patients seen/day, the length of patient visits, number of patient visits to oncology and/or primary care, information systems, and reimbursements?
  • Who should be involved, and how, in the development and delivery of care plans? What are the respective roles of oncology and primary care physicians, nurses, social workers, and other allied health professionals in the care planning process?
  • What systems, organizational and provider-level factors influence the generation, transmission, communication, usability, and ultimate consistent use of survivorship care plans?
  • What incentives and barriers affect adoption of survivorship care planning across diverse healthcare practice settings?
  • What economic strategies could encourage implementation of care planning?
  • Does provider participation in the development of care plans and the care planning process affect implementation of care planning?
  • How can electronic platforms, tools, and applications be harnessed to optimize patient knowledge, patient preparation, and/or care coordination in survivorship care planning?
  • What costs are associated with face-to-face vs. hybrid, automated, or wiki-supported approaches to survivorship care planning?

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-16-012
Funding Opportunity Title: Examination of Survivorship Care Planning Efficacy and Impact (R01)
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
CFDA Number(s): 93.399 — Cancer Control
Cost Sharing or Matching Requirement: No
Posted Date: Oct 23, 2015
Creation Date: Oct 23, 2015
Original Closing Date for Applications: Jan 7, 2019  
Current Closing Date for Applications: Jan 7, 2019  
Archive Date: Feb 7, 2019
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants:
Independent school districts
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
City or township governments
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research evaluating the effect of care planning on self-management of late effects of cancer therapy; adherence to medications, cancer screening, and health behavior guidelines; utilization of follow-up care; survivors’ health and psychosocial outcomes. How organizational-level factors influence the implementation of care planning and its associated costs is also of interest. Specifically, the FOA aims to stimulate research that will: 1) develop and test metrics for evaluating the impact of survivorship care planning; 2) evaluate the impact of survivorship care planning on cancer survivors’ morbidity, self-management and adherence to care recommendations, utilization of follow-up care; 3) evaluate effects of planning on systems outcomes, such as associated costs and impact on providers and organizations implementing the care planning; and 4) identify models and processes of care that promote effective survivorship care planning. The ultimate goal of this FOA is to generate a body of science that will inform the development and delivery of interventions that improve follow-up care for cancer survivors.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-16-012.html
Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Advertisements